Comparison of seizure reduction and serum fatty acid levels after receiving the ketogenic and modified Atkins diet  Natacha Porta, Louis Vallée, Elisabeth.

Slides:



Advertisements
Similar presentations
Demystifying the Fats Caitriona Lordan Dietitian.
Advertisements

Eicosapentaenoic Acid Eicosapentaenoic acid Eicosapentaenoic acid (EPA) is an omega-3 fatty acid.
Peter L. Fisher, Adam J. Noble  Seizure - European Journal of Epilepsy 
Ian Morrison, Saif S.M. Razvi  Seizure - European Journal of Epilepsy 
Examples of Unsaturated Fatty Acids
Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs) 
The impact of the ketogenic diet on arterial morphology and endothelial function in children and young adults with epilepsy: A case–control study  Giangennaro.
Volume 34, Issue 2, Pages (April 2015)
Tong Chen, Liang Guo  Seizure - European Journal of Epilepsy 
Attitudes of employees of service and trading companies towards people with epilepsy and their professional activity in Poland  Talarska Dorota, Monika.
Perri Carlson, Kathryn Nicholson Perry 
Antiepileptic drug therapy the story so far
Has disability discrimination legislation changed the legal framework for epilepsy in the United Kingdom?  Philip Lee  Seizure - European Journal of Epilepsy 
Patients with epilepsy are at an increased risk of subsequent stroke: A population-based cohort study  Chen-Shu Chang, Chun-Hui Liao, Che-Chen Lin, Hsien-Yuan.
Effects of antiepileptic drug on thyroid hormones in patients with epilepsy: A meta- analysis  Yin-Xi Zhang, Chun-Hong Shen, Qi-Lun Lai, Gao-Li Fang, Wen-Jie.
C.-L. Wu, K. Kimmerling, D. Little, F. Guilak 
Midterm -as per course syllabus
Bhimanagouda Patil, Agyepong Oware 
The impact of the ketogenic diet on arterial morphology and endothelial function in children and young adults with epilepsy: A case–control study  Giangennaro.
Oxcarbazepine administration and the serum levels of homocysteine, vitamin B12 and folate in epileptic patients: A systematic review and meta-analysis 
Presentation of adult mitochondrial epilepsy
Do epilepsy specialist nurses use a similar history-taking process as consultant neurologists in the differential diagnosis of patients presenting with.
Anshuman Sengupta, Ali Mahmoud, Shwe Z. Tun, Peter Goulding 
Predicting success of vagus nerve stimulation (VNS) from EEG symmetry
C. C. de Vos, L. Melching, J. van Schoonhoven, J. J. Ardesch, A. W
Hyponatremia following esclicarbazepine therapy
S. Kılınç, C. Campbell  Seizure - European Journal of Epilepsy 
Four types of traditional Chinese medicine inducing epileptic seizures
Four types of traditional Chinese medicine inducing epileptic seizures
Evaluation of clinical aspects and quality of life as risk factors for depression in patients with epilepsy  Ting Zhao, Ming-yue Sun, Pei-min Yu, Guo-xing.
Seizure - European Journal of Epilepsy
Smoking reduces serum levels of lamotrigine
Pediatric first time non-febrile seizure with focal manifestations: Is emergent imaging indicated?  N. Aprahamian, M.B. Harper, S.P. Prabhu, M.C. Monuteaux,
The experience of adjusting to a diagnosis of non-epileptic attack disorder (NEAD) and the subsequent process of psychological therapy  Caroline Wyatt,
Psychogenic non-epileptic seizures—Definition, etiology, treatment and prognostic issues: A critical review  N.M.G. Bodde, J.L. Brooks, G.A. Baker, P.A.J.M.
Depression and anxiety in childhood epilepsy: A review
What patients say about living with psychogenic nonepileptic seizures: A systematic synthesis of qualitative studies  Gregg H. Rawlings, Markus Reuber 
Rui Wang, Hong-Zhi Guan, Hai-Tao Ren, Wei Wang, Zhen Hong, Dong Zhou 
Self-management interventions for epilepsy in people with intellectual disabilities: A scoping review  Michelle Dannenberg, Silvana E. Mengoni, Bob Gates,
Newer antiepileptic drugs compared to levetiracetam as adjunctive treatments for uncontrolled focal epilepsy: An indirect comparison  Zhu Li-na , Chen.
Fracture risk with use of liver enzyme inducing antiepileptic drugs in people with active epilepsy: Cohort study using the General Practice Research Database 
Janelle L. Wagner, Gigi Smith, Pamela Ferguson 
Use of the Precaution Adoption Process Model to examine predictors of osteoprotective behavior in epilepsy  John O. Elliott, Brenda F. Seals, Mercedes.
Beyond standard polysomnography: Advantages and indications for use of extended 10–20 EEG montage during laboratory sleep study evaluations  Ellen J.
Epileptic spasms: Evidence for oral corticosteroids and implications for low and middle income countries  Sharika V. Raga, Jo M. Wilmshurst  Seizure -
Assessing the quality of epilepsy care with an electronic patient record  Mary Fitzsimons, Brendan Dunleavy, Patricia O’Byrne, Mary Dunne, Jane Grimson,
Ali A. Asadi-Pooya, Mehrdad Emami, Alireza Nikseresht 
Oliver Faust, U. Rajendra Acharya, Hojjat Adeli, Amir Adeli 
Peter L. Fisher, Adam J. Noble  Seizure - European Journal of Epilepsy 
Sudden death in epilepsy: Insights from the last 25 years
Milen Pavlović, Nebojša Jović, Tatjana Pekmezović 
Milen Pavlović, Nebojša Jović, Tatjana Pekmezović 
Anina du Toit, Chrisma Pretorius 
HD-tDCS in refractory lateral frontal lobe epilepsy patients
S100B proteins in febrile seizures
Effects of eslicarbazepine acetate on lipid profile and sodium levels in patients with epilepsy  Patrizia Pulitano, Valentina Franco, Oriano Mecarelli,
Antiepileptic drug use in Austrian nursing home residents
Lindsey Hunter, Peter Sidebotham, Richard Appleton, Colin Dunkley 
Seizure - European Journal of Epilepsy
Psychiatric diagnoses of patients with psychogenic non-epileptic seizures  Renato Luiz Marchetti, Daniela Kurcgant, José Gallucci Neto, Mary Ann von Bismark,
Association of the genetic polymorphisms in pre-microRNAs with risk of childhood epilepsy in a Chinese population  Yang Li, Jinqiu Wang, Chunming Jiang,
The mechanisms mediating the antiepileptic effects of the ketogenic diet, and potential opportunities for improvement with metabolism-altering drugs 
Katherine T. Hamilton, Christopher T
Use and costs of concomitant medicines in epileptic patients in Poland: A 12-month prospective multicentre study  Beata Majkowska-Zwolińska, Joanna Jędrzejczak,
Seizure - European Journal of Epilepsy
Blood beta-hydroxybutyrate correlates better with seizure reduction due to ketogenic diet than do ketones in the urine  Renske van Delft, Danielle Lambrechts,
Evolution in VNS therapy for refractory epilepsy, experience with Demipulse devices at Ghent University Hospital  Riëm El Tahry, Veerle De Herdt, Robrecht.
Video ambulatory EEG: A good alternative to inpatient video telemetry?
Diego F. Tovar Quiroga, Jeffrey W. Britton, Elaine C. Wirrell 
Fish oil for prevention of sudden death in hemodialysis patients?
Presentation transcript:

Comparison of seizure reduction and serum fatty acid levels after receiving the ketogenic and modified Atkins diet  Natacha Porta, Louis Vallée, Elisabeth Boutry, Monique Fontaine, Anne-Frédérique Dessein, Sylvie Joriot, Jean-Marie Cuisset, Jean- Christophe Cuvellier, Stéphane Auvin  Seizure - European Journal of Epilepsy  Volume 18, Issue 5, Pages 359-364 (June 2009) DOI: 10.1016/j.seizure.2009.01.004 Copyright © 2009 British Epilepsy Association Terms and Conditions

Fig. 1 Seizure reduction in patients remaining on KD and on modified Atkins diet at 1, 3, 6 and 12 months. Seizure - European Journal of Epilepsy 2009 18, 359-364DOI: (10.1016/j.seizure.2009.01.004) Copyright © 2009 British Epilepsy Association Terms and Conditions

Fig. 2 Level of fatty acids in patient serum before and at 1, 3, 6 and 12 months after the initiation of the KD or the modified Atkins diet. (A) Saturated and monounsaturated fatty acids; (B) Polyunsaturated fatty acids. Start n=17, 1 month n=15; 3 months n=12; 6 months n=7; 12 months n=4. *p≤0.05 in comparison with start; ■, p=0.02 in comparison with 1 month. Myristic: myristic acid (C14:0); palmitic: palmitic acid (C16:0); palmitoleic: palmitoleic acid (C16:1); stearic: stearic acid (C18:0); oleic: oleic acid (C18:1); LA+ALA: linoleic acid (C18:2 n-6)+alpha-linolenic acid (C18:3 n-3); homo lino: homo linoleic acid (C20:3 n-6); EPA: eicosapentaenoic acid (C20:5 n-3); mead: eicosatrienoic (C20:3 n-9); AA: arachidonic acid (C20:4 n-6); DHA: docosahexaenoic acid (C22:6 n-3). Seizure - European Journal of Epilepsy 2009 18, 359-364DOI: (10.1016/j.seizure.2009.01.004) Copyright © 2009 British Epilepsy Association Terms and Conditions

Fig. 3 Levels of fatty acids in responders and in non-responders 1 and 3 months after initiation of the KD and the modified Atkins diet. (A) Data after 1 month of treatment, non-responders (≤50%) n=7; responders (>50%) n=7. (B) Data after 3 months of treatment, non-responders (≤50%) n=6; responders (>50%) n=6. *p≤0.05 in comparison with non-responder group (≤50). Myristic: myristic acid (C14:0); palmitic: palmitic acid (C16:0); palmitoleic: palmitoleic acid (C16:1); stearic: stearic acid (C18:0); oleic: oleic acid (C18:1); LA+ALA: linoleic acid (C18:2 n-6)+alpha-linolenic acid (C18:3 n-3); homo lino: homo linoleic acid (C20:3 n-6); EPA: eicosapentaenoic acid (C20:5 n-3); mead: eicosatrienoic (C20:3 n-9); AA: arachidonic acid (C20:4 n-6); DHA: docosahexaenoic acid (C22:6 n-3). Seizure - European Journal of Epilepsy 2009 18, 359-364DOI: (10.1016/j.seizure.2009.01.004) Copyright © 2009 British Epilepsy Association Terms and Conditions